Category: Medication access

As of July 1, 2025, CVS Caremark removed Zepbound from its standard preferred formulary for many insurance plans, a decision that has caused significant confusion for millions of users. This policy change necessitates a clear understanding of the difference between a retail pharmacy and an insurance plan to properly answer the question: **Does CVS carry Zepbound**?.

Ozempic, a treatment for type 2 diabetes, was approved by the Japanese Ministry of Health, Labour and Welfare in March 2018, but its availability for weight management is complex and highly regulated. This guide explains how to get Ozempic in Japan, distinguishing the different pathways for diabetes and weight loss, and outlining the legal requirements and costs for residents and foreigners.